Eurofins PDMRs Exercise, Sell Shares
Analysis based on 7 articles · First reported May 22, 2026 · Last updated Jun 09, 2026
The market impact of these insider transactions is generally neutral, as they represent routine exercises of stock options and subsequent sales by PDMRs. While they provide transparency into insider activity, the volumes are not significant enough to cause a major shift in the stock price of Eurofins Scientific.
Eurofins Scientific has disclosed several transactions by its Persons Discharging Managerial Responsibilities (PDMRs) in accordance with the Europepean Market Abuse Regulation. Laurent Lebras, Group CFO, exercised 1000 stock options and sold 1000 shares on June 8, 2026, at EUR 65.00. He also exercised 6000 stock options and sold 6000 shares on June 4, 2026, at an aggregated price of EUR 64.3333. Additionally, he exercised 1000 stock options and sold 1000 shares on June 5, 2026, at EUR 65.00. François Vigneau, Senior Vice President, exercised 700 stock options on May 7, 2026, at EUR 33.69, and sold 1000 shares on June 4, 2026, at EUR 62.40. These transactions are linked to the Eurofins Scientific stock option program.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard